Testosterone Cypionate for Injection recalled over manufacturing violations
- Recall date
- January 14, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Sun Pharmaceutical Industries, Inc. recalls Testosterone Cypionate for Injection, 2,000 mg/10 mL (200 mg/mL), a) 1 mL Single Use vial (NDC 62756-015-40) and b) 10…
- Recall number
- D-0788-2020
- FDA classification
- Class II
- Brand / firm
- Sun Pharmaceutical Industries, Inc.
- Sold / distributed
- Product was distributed throughout the United States.
Why it was recalled
cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Testosterone Cypionate for Injection, 2,000 mg/10 mL (200 mg/mL), a) 1 mL Single Use vial (NDC 62756-015-40) and b) 10 mL Multiple Dose Vial (NDC 62756-016-40), Rx only, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceuticals, Industries, Ltd., Gujarat, India
Get recall alerts
Free email alert whenever Sun Pharmaceutical Industries, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sun Pharmaceutical Industries, Inc.